Literature DB >> 25046199

Histopathological screening for prostate carcinoma: is a benign biopsy a negative biopsy?

Verena Sailer1, Glen Kristiansen.   

Abstract

In case of clinical suspicion of a prostate malignancy, a prostate biopsy is the most widely used approach to confirm prostate cancer. Unfortunately, exclusion of prostate cancer is not feasible by means of biopsy and also the negative rate remains consistently high. Here, we review the information the surgical pathologist can still gain from a prostate biopsy in absence of overt carcinoma.
© 2014 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ASAP; PIA; PIN; Prostate; biopsy

Mesh:

Substances:

Year:  2014        PMID: 25046199     DOI: 10.1111/apm.12291

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  3 in total

Review 1.  [Intraductal carcinoma of the prostate].

Authors:  G Kristiansen; M Varma; G Seitz
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

2.  Editorial: Prostate Cancer: What We Know and What We Would Like to Know.

Authors:  Gianluigi Taverna; Richard J Cote; Fabio Grizzi
Journal:  Front Oncol       Date:  2015-05-22       Impact factor: 6.244

Review 3.  Sniffing out prostate cancer: a new clinical opportunity.

Authors:  Gianluigi Taverna; Lorenzo Tidu; Fabio Grizzi
Journal:  Cent European J Urol       Date:  2015-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.